Recent posts

TypePostAuthorRepliesLast updated
Blog entryBiden presses Colombia to block biosimilar drugs James Love02 days 16 hours ago
Blog entryWIPO's new Senior Management Team: New faces for Copyright, Development, Global Issues and Patents thiru03 days 16 hours ago
Blog entryKEI welcomes the Gilead HCV licenses, as a step to expand access to treatments. Notes challenges that remain KEI Staff04 days 15 hours ago
Blog entryThe Gilead HCV license: Glass half empty, or half full? James Love04 days 16 hours ago
Blog entrySenate HELP subcommittee hearings on S.1138, the HIV/AIDS prize fund James Love01 week 3 days ago
Blog entrySenator Wyden in 2012, on access to the TPP text Claire Cassedy01 week 3 days ago
Book pageFunding James Love01 week 3 days ago
PageDonate to KEI James Love02 weeks 1 day ago
Blog entryWIPO General Assembly 2014: Hard Decisions on the Broadcast Treaty and work program on copyright limitations and exceptions thiru02 weeks 2 days ago
Blog entryWIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources thiru02 weeks 3 days ago
Blog entryJanuary 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer thiru02 weeks 4 days ago
Blog entry13 May 2014: WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation thiru03 weeks 2 days ago
Blog entryTDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up thiru04 weeks 4 days ago
PageThe Big Idea: Prizes to Stimulate R&D for New Medicines thiru04 weeks 6 days ago
Book pageJames Love, Director James Love04 weeks 6 days ago
Blog entryOMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions James Love05 weeks 12 hours ago
Book pageCPTech's 2003 reports for the RSA Competition Commission, in Hazel Tau et al.v GSK, Boehringer, et al KEI Staff05 weeks 2 days ago
PageThe USTR Special 301 Reports, 1989 to 2014 James Love05 weeks 3 days ago
Blog entryGilead's US patient access programs for Sovaldi Elizabeth Rajasingh05 weeks 5 days ago
Blog entrySome recent cancer drug prices James Love06 weeks 4 days ago
Blog entryMoney speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP KEI Staff06 weeks 5 days ago
Blog entryUS proposal: IGC Work Plan for 2015-Is the IGC train leaving the station? thiru06 weeks 5 days ago
Blog entryGilead's MPP license for tenofovir alafenamide (TAF) patents James Love07 weeks 1 day ago
PageElizabeth Rajasingh, Perls Fellow Elizabeth Rajasingh07 weeks 2 days ago
Book pageHepatitis C Claire Cassedy07 weeks 2 days ago